EMC
45
3
DHR
56
-4
KEY
53
3
QCOM
57
2
CB
58
-2
SYY
58
2
FOX
37
6
AIV
62
-3
TEL
63
2
AIZ
73
4
R
67
4
EL
33
3
WBA
27
2
EA
46
-6
EFX
69
-6
SYF
65
7
AAP
23
2
PNW
66
-3
GOOG
61
2
DFS
56
2
EMC
45
3
DHR
56
-4
KEY
53
3
QCOM
57
2
CB
58
-2
SYY
58
2
FOX
37
6
AIV
62
-3
TEL
63
2
AIZ
73
4
R
67
4
EL
33
3
WBA
27
2
EA
46
-6
EFX
69
-6
SYF
65
7
AAP
23
2
PNW
66
-3
GOOG
61
2
DFS
56
2
Financhill
Back

Genmab AS Stock Predictions

"The Next Apple?" - Mode's Growth Story is Turning Heads

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
22

GMAB
Genmab AS

Last Price:
26.19
Seasonality Move:
6.18%

7 Day Trial

ALL ACCESS PASS

$ 7

The Next Tech Giant in Your Pocket?

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Genmab AS Stock Forecast

  • Over the next 52 weeks, Genmab AS has on average historically risen by 28.4% based on the past 11 years of stock performance.
  • Genmab AS has risen higher in 8 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 72.73%
  • Is Genmab AS Stock Undervalued?
    The current Genmab AS [GMAB] share price is $26.43. The Score for GMAB is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • GMAB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Genmab AS Stock Go Up Next Year?

  • Over the next 52 weeks, Genmab AS has on average historically risen by 28.4% based on the past 11 years of stock performance.

Genmab AS Stock Rating

Sell
22
Genmab AS (GMAB) is a Sell

Is Genmab AS overpriced?

  • Genmab AS has risen higher in 8 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 72.73%

Genmab AS Stock Price History

Is GMAB stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GMAB is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Denmark
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
genmab.com

52-Week Data

52-Week High:
37.97
52-Week Low:
24.53

Prediction Charts

Market Cap:
16.78B
Price in USD:
26.43
Volume:
321.1K
Beta:
0.71

Technical Analysis

SMA50:
27.24
SMA100:
27.46
SMA200:
28.64
52-Wk Change:
-30.41%

Stock Predictions

  • Is Genmab AS stock public?
    Yes, Genmab AS is a publicly traded company.
  • What is the Genmab AS stock quote today?
    The Genmab AS stock price is 26.43 USD today.
  • How to buy Genmab AS stock online?
    You can buy Genmab AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Aug-28 27.77 27.70 27.86 27.64
Aug-29 27.84 27.81 27.93 27.74
Aug-30 27.72 27.80 27.86 27.62
Sep-3 27.73 27.42 27.81 27.38
Sep-4 27.43 27.59 27.73 27.42
Sep-5 27.80 27.71 27.82 27.54
Sep-6 27.82 27.50 27.91 27.46
Sep-9 27.39 27.46 27.62 27.34
Sep-10 27.62 27.50 27.62 27.38
Sep-11 27.15 26.94 27.18 26.68
Sep-12 26.66 26.48 26.71 26.28
Sep-13 26.55 26.90 26.90 26.55
Sep-16 26.75 26.58 26.77 26.39
Sep-17 26.54 26.43 26.59 26.36

Genmab AS Earnings

Genmab AS Earnings Report: Per Share Genmab AS Earnings Q1 Q2 Q3 and Q4 last year and next year.

Genmab AS Forecast Revenue Growth

Genmab AS Stock Analysis: Historical quarterly revenues per share for Genmab AS and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.10 per share, an increase this year of $0.15 per share, and an increase next year of $0.33 per share.

* Genmab AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.